Recommendation: Buy
| Entry Date | Symbol | Recommendation | Entry Price (USD) | Target 1 (USD) | Target 2 (USD) | Holding Duration | Position Status | Return(%)* |
|---|---|---|---|---|---|---|---|---|
| 28 Apr, 26 | WELL | Buy | USD 210.0 | USD 221.0 | USD 232.0 | 65 days | Closed |
10.69%
|
*Return(%) represent the percentage change between the entry price and exit price of the recommendation.
Data Powered by EOD Historical Data (“EODHD”).
Welltower Inc. (NYSE:WELL), a real estate investment trust (REIT) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower, owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties.
Revenue Growth: USD 10,838.0 Mn in FY25 vs USD 7,991.1 Mn in FY24
Improvement in Same Store NOI: USD 643.3 Mn in Q4FY25 vs USD 559.4 Mn in Q4FY24
Increase in General & Administrative Expenses: USD 1,748.4 Mn in FY25 vs USD 235.5 Mn in FY24
Decline in Net Income Per Share: USD 1.39 in FY25 vs USD 1.57 in FY24
The company remains exposed to operator performance risk and macroeconomic factors, including interest rate volatility and healthcare regulatory changes, which could impact occupancy levels, rent collections, and overall profitability
| Entry Price | Support* | Target 1** | Target 2** |
|---|---|---|---|
| 210.0 | 189.0 | 221.0 | 232.0 |
Data Source: REFINITIV, Analysis: StockNextt
*Support can be considered as an indicative stop-loss, and if prices move below that level on closing basis individuals may evaluate exiting the position depending on their risk appetite, previous holdings, and other factors considered. The support and resistance levels may need to be re-evaluated within 4-6 weeks’ time frame depending on the stock price movements from the date of recommendation on the stock.
**Target prices may vary by ±0.5% depending on market volatility.
Robust Operating Momentum and Earnings Expansion in FY25: Welltower Inc. (NYSE: WELL) delivered a strong operational and financial performance in FY25, supported by robust growth across its core seniors housing portfolio. The company reported normalized funds from operations (FFO) of USD 5.29 per diluted share, reflecting a notable 22.5% year-over-year increase, driven by improved occupancy, pricing strength, and operational efficiencies. Net income attributable to common stockholders stood at USD 1.39 per diluted share, highlighting stable earnings generation despite elevated cost pressures and portfolio transitions.
Seniors Housing Portfolio Driving NOI and Revenue Growth: The seniors housing operating (SHO) portfolio remained the primary growth engine, with same-store NOI rising 20.4% year-over-year in Q4FY25. This was supported by a 9.6% increase in same-store revenue, driven by a 400 basis point improvement in occupancy levels and a 4.7% increase in revenue per occupied room (RevPOR). Margin expansion was also evident, with same-store NOI margins improving by 270 basis points, reflecting strong operating leverage and cost optimization initiatives.
Strong Top-Line Expansion Across Segments: The company reported total revenues of USD 10.84 billion in FY25, up from USD 7.99 billion in FY24, driven by higher resident service fees and rental income growth. Resident fees and services revenue increased significantly to USD 8.45 billion, reflecting higher occupancy and pricing power in the seniors housing segment. Rental income also rose to USD 1.97 billion, supported by portfolio expansion and favorable lease dynamics.
Strategic Capital Deployment and Portfolio Optimization: Welltower continued to actively reshape its portfolio through large-scale investments and dispositions. During Q4FY25, the company completed USD 13.9 billion in gross investments and USD 7.5 billion in dispositions and loan repayments, exceeding prior expectations. The strategic divestment of lower-growth outpatient medical assets and reinvestment into high-growth seniors housing properties enhanced long-term earnings visibility and portfolio quality.
Balance Sheet Strength and Liquidity Position: The company maintained a strong balance sheet with net debt to adjusted EBITDA at 3.03x and liquidity of approximately USD 10.2 billion as of December 31, 2025. Additionally, net debt to enterprise value improved to 10.0% from 12.9% in the prior year, reflecting disciplined capital management and deleveraging efforts. These metrics underline Welltower’s financial flexibility to pursue future growth opportunities while maintaining a conservative leverage profile.
Expansion Through Strategic Acquisitions and Partnerships: Welltower strengthened its global footprint through significant acquisitions, including the £5.2 billion Barchester portfolio and £1.2 billion HC-One acquisition in the U.K. These transactions expanded its presence in high-growth markets and are expected to generate long-term cash flow growth with favorable IRR profiles. The company also launched private investment vehicles, securing USD 2.5 billion in equity commitments, further enhancing its capital-light growth strategy.
Dividend Growth and Positive Outlook: Reflecting strong cash flow generation, the company increased its quarterly dividend by 10.4% in FY25, supported by a low payout ratio and robust earnings growth. Looking ahead, management expects normalized FFO in the range of USD 6.09 to USD 6.25 per share in FY26, indicating continued momentum supported by favorable demographic trends and operational improvements across its portfolio.
Considering recent key business, financial updates, current trading levels, and key business risks, a ‘Buy’ recommendation has been given to Welltower Inc. (NYSE: WELL) at the closing market price of USD 210.0, as on 27 April,2026.
Data Powered by EOD Historical Data (“EODHD”).
Sector: Real Estate Industry: REIT - Healthcare Facilities
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| WELL Welltower Inc |
1.59 0.65% | 244.84 | 170.68 | 72.46 | 7.75 | 2.13 | 9.77 | 27.67 |
| VTR Ventas Inc |
0.15 0.16% | 96.25 | 2524.00 | 25.51 | 4.47 | 1.98 | 7.44 | 17.76 |
| DOC Healthpeak Properties Inc |
-0.22 0.98% | 22.29 | 164.70 | 113.64 | 4.06 | 1.58 | 7.64 | 13.08 |
| AHR American Healthcare REIT, Inc. |
-0.5 0.87% | 56.66 | 117.90 | 61.73 | 4.21 | 2.90 | 4.96 | 31.16 |
| CTRE CareTrust REIT Inc. |
-0.43 1.00% | 42.45 | 24.43 | 21.32 | 17.98 | 2.18 | 25.71 | 20.56 |
Data Powered by EOD Historical Data (“EODHD”).
Markets are trading in a highly volatile zone currently due to certain macro-economic issues and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.
Related Risks: This report may be looked at from high-risk perspective and recommendations are provided are for a short duration. Recommendations provided in this report are solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc.
Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels as on April 28, 2026. The reference data in this report has been partly sourced from REFINITIV.
Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned has been achieved and is subject to the factors discussed above.
Note 4: StockNextt reports are prepared based on the stock prices captured either from REFINITIV or Trading View. Typically, REFINITIV or Trading View may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.
Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.
Target: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Target 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Target 2 may act as the crucial resistance level for the stock.
Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.
Disclaimer :
This report has been issued by StockNextt which has an Ontario Business Identification Number 1000958347 and British Columbia registration Number FM1051529 is a trade name under Kalkine Canada Advisory Services Inc. having Business Number 761925130BC0001. Kalkine Canada Advisory Services Inc. and StockNextt are collectively referred to as “StockNextt”, “we”, “us”, and “our”. The website https://stocknextt.com and associated pages are published by StockNextt. The information in this report and on the StockNextt website has been prepared from a wide variety of sources, which StockNextt, to the best of its knowledge and belief, considers accurate. StcokNextt has made every effort to ensure the reliability of information contained in its reports, newsletters, and websites. All information represents our views at the date of publication and may change without notice. The information in this report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain general recommendations for investing in securities and other financial products. StockNextt does not offer financial advice based upon your personal financial situation or goals, and we shall not be held liable for any investment or trading losses you may incur by using the opinions expressed in our reports, publications, market updates, news alerts and corporate profiles. StockNextt does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. StockNextt’s general advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested. Please also read our Terms and conditions for further information. Employees and/or associates of StockNextt and its related entities may hold an interest in the securities or other financial products covered in this report or on the StockNextt website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.
Copyright © 2026 Krish Capital Pty Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.
Australia